You are here

Vertex Pharmaceuticals

Where Will Vertex Pharmaceuticals Be in 10 Years?

Where Will Vertex Pharmaceuticals Be in 10 Years?

Motley Fool

Vertex Pharmaceuticals

cystic fibrosis

sickle cell disease

Flag link:

What to know about the U.K.’s approval of the first CRISPR treatment for diseases

What to know about the U.K.’s approval of the first CRISPR treatment for diseases

Nature

Vertex Pharmaceuticals

CRISPR Therapeutics

Flag link:

Vertex, CRISPR Win World’s First Approval for CRISPR-Edited Therapy from UK

Vertex, CRISPR Win World’s First Approval for CRISPR-Edited Therapy from UK

BioSpace

Vertex Pharmaceuticals

CRISPR Therapeutics

beta thalassemia

Flag link:

Cell & Gene Therapy Space Gears Up for First CRISPR Approval

Cell & Gene Therapy Space Gears Up for First CRISPR Approval

BioSpace

sickle cell disease

Vertex Pharmaceuticals

CRISPR Therapeutics

Flag link:

Bluebird won't play off Vertex in deciding price for its lovo-cel gene therapy, exec says

Bluebird won't play off Vertex in deciding price for its lovo-cel gene therapy, exec says

Fierce Pharma

Vertex Pharmaceuticals

sickle cell disease

Flag link:

As Vertex preps for exa-cel launch, exec touts 'very large' opportunity but tempers early expectations

As Vertex preps for exa-cel launch, exec touts 'very large' opportunity but tempers early expectations

Fierce Pharma

Vertex Pharmaceuticals

Flag link:

FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study

FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study

Yahoo/Reuters

Vertex Pharmaceuticals

CRISPR Therapeutics

Flag link:

Tracking the FDA’s meeting on Vertex, CRISPR’s sickle cell therapy

Tracking the FDA’s meeting on Vertex, CRISPR’s sickle cell therapy

BioPharma Dive

Vertex Pharmaceuticals

sickle cell disease

Flag link:

FDA Flags Off-Target Effects of Vertex, CRISPR’s Sickle Cell Therapy Ahead of Adcomm

FDA Flags Off-Target Effects of Vertex, CRISPR’s Sickle Cell Therapy Ahead of Adcomm

BioSpace

Vertex Pharmaceuticals

sickle cell disease

Flag link:

Vertex gearing up for launch as sickle cell therapy review advances

Vertex gearing up for launch as sickle cell therapy review advances

BioPharma Dive

Vertex Pharmaceuticals

sickle cell disease

Flag link:

Vertex Presents Positive, Updated VX-880 Results From Ongoing Phase 1/2 Study in Type 1 Diabetes at the European Association for the Study of Diabetes 59th Annual Meeting

Vertex Presents Positive, Updated VX-880 Results From Ongoing Phase 1/2 Study in Type 1 Diabetes at the European Association for the Study of Diabetes 59th Annual Meeting

Businesswire

Vertex Pharmaceuticals

clinical trials

type 1 diabetes

Flag link:

Vertex gets in on GPCR game, paying Septerna $47M for undisclosed program

Vertex gets in on GPCR game, paying Septerna $47M for undisclosed program

Fierce Biotech

Vertex Pharmaceuticals

Flag link:

Promising Vertex Pain Med Points to New Era for Analgesics

Promising Vertex Pain Med Points to New Era for Analgesics

BioSpace

Vertex Pharmaceuticals

post-surgical pain

Flag link:

Aiming to be biggest biotech in Boston, Vertex plots 500-person cell, gene therapy R&D center

Aiming to be biggest biotech in Boston, Vertex plots 500-person cell, gene therapy R&D center

Fierce Biotech

Vertex Pharmaceuticals

Flag link:

First-ever CRISPR-CAS9 therapy, exa-cel, shows promising results

First-ever CRISPR-CAS9 therapy, exa-cel, shows promising results

Clinical Trials Arena

Vertex Pharmaceuticals

beta thalassemia

Flag link:

Vertex Pharma raises full-year revenue forecast on cystic fibrosis treatment strength

Vertex Pharma raises full-year revenue forecast on cystic fibrosis treatment strength

Yahoo/Reuters

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

U.S. watchdog lifts price estimate for Bluebird, Vertex/CRISPR gene therapies to $2.1 million

U.S. watchdog lifts price estimate for Bluebird, Vertex/CRISPR gene therapies to $2.1 million

Reuters

Vertex Pharmaceuticals

CRISPR Therapeutics

sickle cell disease

Flag link:

Gene Editing Race Between Editas and Vertex, CRISPR Heats Up

Gene Editing Race Between Editas and Vertex, CRISPR Heats Up

BioSpace

Editas Medicine

Vertex Pharmaceuticals

CRISPR Therapeutics

sickle cell disease

beta thalassemia

Flag link:

Pages